Trial Details
UNKNOWNBasic Information
| Clinical ID | c717 |
|---|---|
| Identifier | NCT06175949 |
| Trial Title | A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | DRUG: HRS-7085 Tablets|DRUG: HRS-7085 simulant |
Participant Information
| Sponsor | Shandong Suncadia Medicine Co., Ltd. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-12 |
|---|---|
| Primary Completion Date | 2024-06 |
| Completion Date | 2024-07 |